The surgical robotics landscape is undergoing a fundamental structural evolution. For two decades, monolithic, closed, single-vendor architectures controlled the industry. Today, that landscape has fragmented into a vibrant ecosystem of specialized OEMs. As the market heads toward a projected value of $27.1B by 2030, Tier-1 medical device innovators are shifting away from building proprietary hardware infrastructures, focusing instead on software differentiation and clinical breakthroughs.

In medical robotics, sub-millisecond precision is not a feature – it is a non-negotiable requirement. Whether the application is diagnostic imaging, patient care, rehabilitation, or surgical intervention, any discrepancy or micro-delay (jitter) between a clinician's command and the robotic arm's actual physical response can compromise spatial alignment and clinical precision. For OEMs developing next-generation medical platforms, achieving true real-time synchronization across hardware components is a monumental engineering challenge.

The medical robotics industry is entering a new era. With the global market projected to grow from $13.7B in 2025 to over $27B by 2030, medical device manufacturers (OEMs) face a critical question: how do you build a robotic platform that is not only mechanically precise, but seamlessly integrated into the full clinical ecosystem?That question is exactly what Kinova and RTI set out to answer together.

Bringing a medical robotic arm from concept to clinical commercialization is a race against time, weighed down by immense regulatory gravity. For Medical Device Manufacturers (OEMs), the longest and most costly phase is rarely the design – it is the development, documentation, and validation of safety-critical software. In an industry spanning diagnostics, patient care, and surgical intervention – where software failure can have direct clinical consequences – cutting corners is not an option, but traditional development methods are stalling innovation.

On May 19th, Kinova celebrated its 20th anniversary, marking two decades of innovation and contribution to the evolution of robotics. To crown this historic milestone, the proudly Canadian company is taking a major new step by announcing the official launch of KIMA, its brand-new medical robotic arm designed specifically for clinical environments. This launch reaffirms Kinova’s position as a key international player, propelling its cutting-edge technologies from assistive applications to high-precision medical robotics. The official unveiling will take place at the Society of Robotic Surgery (SRS) 2026 annual meeting.

Join Kinova at the Society of Robotic Surgery (SRS) Annual Meeting, taking place July 23–26, 2026, at the Diplomat Beach Resort in Hollywood, Florida. Visit us at booth #415 to discover KIMA, our new medical robotic arm purpose-built from the ground up for healthcare and operating room environments.

Kinova will be attending the Hamlyn Symposium, an internationally recognized event for researchers, clinicians, and engineers shaping the future of medical robotics.